ing the general public, cancer patients, clinicians, policy makers, advocacy groups, health researchers, and insurers. An overview of key discussion points raised by individual presenters is provided below.
The workshop agenda, statement of task, and speaker biographies are in Appendixes A and B. The speakers’ presentations (PDF and audio files) have been archived at www.iom.edu/Activities/Disease/NCPF/2012-JUN-11.aspx.
Overview of Key Points Highlighted by Individual Participants
Clinicians can improve their patients’ health by
• Recognizing and treating nicotine dependence as a serious chronic medical problem.
• Incorporating tobacco assessment and cessation support as a standard part of clinical care for all patients.
• Discussing the immediate and long-term cardiovascular, pulmonary, cancer, and other related health benefits associated with tobacco cessation at every patient encounter.
• Recommending and/or providing evidence-based tobacco cessation therapy, including counseling and medication, for all patients who use tobacco.
• Providing consistent and repeated counseling for tobacco cessation at every patient encounter.
Cancer care could be improved by
• Accurately identifying tobacco use in cancer patients during and following cancer treatment using structured tobacco assessments and/or biochemical confirmation methods.
• Incorporating the treatment of tobacco dependence into the standard of care for all cancer patients who use tobacco products, to improve treatment outcomes and reduce treatment complications and toxicity.
• Ensuring that all institutions that treat cancer patients have evidence-based tobacco cessation programs as a requirement for accreditation.
• Mandating dedicated cessation support as a standard requirement for National Cancer Institute (NCI) Cancer Center Designation.